Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplantation for Myelofibrosis
NCT00002792Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 1996
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide in primary myelofibrosis (PMF), myeloproliferative disorder (MPD), sponsored by Fred Hutchinson Cancer Center. Started Jun 1996; status: completed.
02
Drugs
busulfancyclophosphamide
03
Conditions
primary myelofibrosis (PMF)myeloproliferative disorder (MPD)
Beyond the preview
Go deeper on NCT00002792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002792.